# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Ascendiant Capital analyst Edward Woo maintains Envoy Medical (NASDAQ:COCH) with a Buy and raises the price target from $8.7...
Envoy Medical (NASDAQ:COCH) reported quarterly losses of $(0.37) per share which missed the analyst consensus estimate of $(0.2...
Study in Otology & Neurotology outlines early experiences and potential benefits of breakthrough fully implanted cochlear i...
Envoy Medical®, Inc. ("Envoy Medical") (NASDAQ: "COCH"), a hearing health company focused on fully implanted he...